Advertisement
Research Article|Articles in Press

Outcomes of an Advanced Speech and Language Therapist-Led Low-Risk 2-Week Wait Clinic for Suspected Head and Neck Cancer: A UK-Based Pilot Study

Published:April 04, 2023DOI:https://doi.org/10.1016/j.jvoice.2023.02.007
Outcomes of an Advanced Speech and Language Therapist-Led Low-Risk 2-Week Wait Clinic for Suspected Head and Neck Cancer: A UK-Based Pilot Study
Previous ArticleEvaluation of Safety After Intracordal Basic Fibroblast Growth Factor Injection
Next ArticleSmartphone Recordings are Comparable to “Gold Standard” Recordings for Acoustic Measurements of Voice

      Summary

      Objectives

      To describe outcomes of a pilot Speech and Language Therapist led (SLT-led) 2-week wait (2WW) assessment clinic for head and neck cancer (HNC).

      Study Design

      A prospective 3-month pilot clinic was conducted. All referrals were triaged by an otolaryngologist. Referrals for unilateral symptoms, palpable neck lumps and/or ear pain were excluded. SLTs performed initial assessment. All patients received oral and neck examinations, and a videolaryngoscopy, including therapy trials. All images and management plans were discussed with an otolaryngologist within one week of the clinic. Images of suspicious lesions were reviewed within 24 hours. Data were collected consecutively for all patients attending the clinic between December 2021 and March 2022. Data included demographics, smoking history, perceptual voice ratings (GRBAS), validated patient-reported outcome measures (PROMs), diagnoses, and clinical plans. Descriptive statistics were conducted within Excel and inferential statistics within SPSS.

      Results

      Over 3 months, 218 patients were seen, 62% were female and the mean age was 63 years. Most patients (54%) opted for “patient initiated follow-up” and 16% received further investigations. No patients required Ear, Nose and Throat (ENT) outpatient review for second opinion. Most (65%) received a functional diagnosis. The diagnostic yield of cancer was 5% (n = 11) and high-grade dysplasia was 3% (n = 6). At the time of writing, no patients had been re-referred to the service. There was a positive relationship between risk of diagnosis and mean GRBAS score (P < 0.01), and VHI-10 score (p=0.013). Patients with higher-risk diagnoses tended to be male, older, and had a history of smoking. PROMs suggested that laryngeal symptoms, regardless of underlying pathology, affect quality of life.

      Conclusion

      Experienced SLTs working alongside otolaryngologists safely led assessment and directed treatment planning for patients referred to ENT on the 2WW pathway. The rate of high-risk diagnoses was low. Higher GRBAS and VHI-10 scores may be useful indicators for higher risk diagnoses.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Voice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

      1. Cancer Research UK. Head and neck cancers statistics [Internet]. 2017 [cited 2022 Aug 18]. Available at:https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/head-and-neck-cancers. Accessed May 5, 2022

        View in Article

      2. Cancer Data. National Cancer Registration and Analysis Service (NCRAS) [Internet]. 2022 Available at: https://www.cancerdata.nhs.uk/. Accessed May 5, 2022

        View in Article
        • Occomore-Kent L
        • Slade S.
        Speech and language therapy assessment of patients on the 2-week wait head and neck cancer referral pathway: evidence and opinion following a pilot study.
        Curr Opin Otolaryngol Head Neck Surg. 2021; 29: 179-186
        View in Article
        • Hardman JC
        • Tikka T
        • Paleri V
        • et al.
        Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: a prospective population-based study.
        Cancer. 2021; 127: 4177-4189
        View in Article

      5. NICE. Symptoms suggestive of head and neck cancers | Diagnosis | Head and neck cancers - recognition and referral | CKS | NICE [Internet]. 2015 [cited 2022 Aug 18]. Available at: https://cks.nice.org.uk/topics/head-neck-cancers-recognition-referral/diagnosis/symptoms-suggestive-of-head-neck-cancers/. Accessed May 5, 2022

        View in Article
        • Mettias B
        • Charlton A
        • Ashokkumar S.
        Two-week-wait referrals in otolaryngology in a tertiary centre: cross-sectional study of benign outcomes, with a systematic review.
        J Laryngol Otol. 2022; 136: 1051-1055
        View in Article

      7. Jones SM, Awad R, Esposito K, et al. RCSLT position paper: speech and language therapist endoscopic evaluation of the larynx EEL for clinical voice disorders [Internet]. RCSLT; 2020. Available at:https://www.rcslt.org/wp-content/uploads/media/docs/clinical-guidance/RCSLT_Endoscopy-position-paper.pdf?la=en&hash=103BE5E2D331AB5699524FBF9BC885BE7127B13E. Accessed May 15, 2022

        View in Article
        • Bradley PT
        • Patterson J.
        Attitudes to the implementation of speech and language therapist led low risk two week wait clinic in the UK: a survey exploration using normalization process theory.
        J Voice [Internet]. 2021; ([cited 2022 Jul 5]. Available at:) (Accessed May 15, 2022)
        https://www.sciencedirect.com/science/article/pii/S0892199721002125
        View in Article
        • Rosen CA
        • Lee AS
        • Osborne J
        • et al.
        Development and validation of the voice handicap index-10.
        Laryngoscope. 2004; 114: 1549-1556
        View in Article

      10. Belafsky PC, Mouadeb DA, Rees CJ, et al. Validity and reliability of the eating assessment tool (EAT-10) [Internet]. 2014 [cited 2022 Jul 5]. Available at:https://journals.sagepub.com/doi/abs/10.1177/000348940811701210. Accessed May 10, 2022

        View in Article
        • Vertigan A.E.
        • Bone S.L.
        • Gibson P.G
        Development and validation of the Newcastle laryngeal hypersensitivity questionnaire.
        Cough. 2014; 10: 1-13
        View in Article
        • Paleri V
        • Hardman J
        • Tikka T
        • et al.
        Rapid implementation of an evidence-based remote triaging system for assessment of suspected referrals and patients with head and neck cancer on follow-up after treatment during the COVID-19 pandemic: model for international collaboration.
        Head Neck. 2020; 42: 1674-1680
        View in Article
        • Van Houtte E
        • Van Lierde K
        • D'Haeseleer E
        • et al.
        The prevalence of laryngeal pathology in a treatment-seeking population with dysphonia.
        Laryngoscope. 2010; 120: 306-312
        View in Article
        • Wilson J a.
        • Deary I j.
        • Millar A
        • et al.
        The quality of life impact of dysphonia.
        Clin Otolaryngol Allied Sci. 2002; 27: 179-182
        View in Article
        • Naunheim MR
        • Goldberg L
        • Dai JB
        • et al.
        Measuring the impact of dysphonia on quality of life using health state preferences.
        Laryngoscope. 2020; 130: E177-E182
        View in Article
        • da Cunha Pereira G
        • de Oliveira Lemos I
        • Dalbosco Gadenz C
        • et al.
        Effects of voice therapy on muscle tension dysphonia: a systematic literature review.
        J Voice. 2018; 32: 546-552
        View in Article
        • Payten CL
        • Eakin J
        • Smith T
        • et al.
        Outcomes of a multidisciplinary ear, nose and throat allied health primary contact outpatient assessment service.
        Clin Otolaryngol. 2020; 45: 904-913
        View in Article
        • Schwarz M
        • Ward EC
        • Seabrook M
        • et al.
        Outcomes from an extended scope of practice speech-language pathology service for low risk ENT outpatients: a 5-year service review.
        Int J Speech Lang Pathol. 2022; 24: 3-11
        View in Article

      Article info

      Publication history

      Published online: April 04, 2023
      Accepted: February 7, 2023

      Publication stage

      In Press Corrected Proof

      Identification

      DOI: https://doi.org/10.1016/j.jvoice.2023.02.007

      Copyright

      Crown Copyright © 2023 Published by Elsevier Inc. on behalf of The Voice Foundation. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX